The 2nd Annual
Singapore, 16 March 2017Book Now
Since Regulation Asia’s last OTC Derivatives Summit, new uncertainties have emerged. Extant challenges—such as banks’ struggle for profitability amid shrinking balance sheets and increasingly burdensome capital adequacy requirements—appear no closer to being resolved.
A seeming lack of regulatory coordination, exemplified by Hong Kong, Singapore, Australia and Japan not carrying through with the 1 September deadline for initial margin, has only added to the problem.
This raft of uncertainties means that one year on, it has become harder, not less difficult, to predict how Asia-Pacific’s OTC derivatives markets will evolve. Yet it also means the imperative to attempt to understand where we stand, and where we're going, has become even stronger.
With this ultimate objective in mind, the 2017 OTC Derivatives Summit will explore issues including:
Impact of capital requirements on banks in Asia-Pacific. A shift in roles
CCPs – Global vs local. Development of Asia based CCPs
Shifting deadlines: Impact of delays with IM/VM – where are we in Asia?
Uncleared OTC derivatives margin reforms and implications for counterparties
Updates on SA-CCR and FRTB Implementation
Divergence between US/Europe & Asia regulators
Combination of keynotes, panels, interactive sessions and networking
Hear from Regulators, Senior Market Participants, Technologists and Peers.
Network and discuss with your market peers from across Asia-Pacific.
Register today to ensure you take advantage of this exclusive 1-day summit